Skip to content
OpenCapital
Get started

West Pharmaceutical Services WST Net Change in Cash

Net Change in Cash at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$64M+194%
AptarGroup logo
AptarGroupATR
-$179.9M-83.6%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$175.59M+190%
AVT
AvantorAVTR
-$86.1M-260%
Dow logo
DowDOW
$283M+140%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
-$7M+92.1%

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$23.72B+32.5%
Enterprise value$23.6B+33.4%
P/E42×+5.3×
P/S7.1×+1.1×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is West Pharmaceutical Services's net change in cash?
West Pharmaceutical Services (WST) reported net change in cash of -$85.6M in Q2 2026.
How has West Pharmaceutical Services's net change in cash changed year-over-year?
West Pharmaceutical Services's net change in cash decreased by 181.1% year-over-year, from $105.5M to -$85.6M.
What is the long-term trend for West Pharmaceutical Services's net change in cash?
Over 2 years (2021 to 2025), West Pharmaceutical Services's net change in cash has grown at a 44.4% compound annual growth rate (CAGR), from $147.1M to $306.7M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.